Equibles does not estimate personal net worth.
Get an email with a short summary when Bausch Health Companies Inc. publishes a filing, an earnings call transcript or a press release.
Get BHC alertsJoseph Papa is recorded as CEO at Bausch Health Companies Inc. (BHC), CEO at Bausch & Lomb Corp (BLCO), Board Member at Emergent BioSolutions Inc. (EBS) since January 1, 2024 and CEO at Emergent BioSolutions Inc. (EBS). The newest filing on record that lists Joseph Papa as CEO and Board Member at Emergent BioSolutions Inc. (EBS) is dated March 20, 2026. The proxy statement of Emergent BioSolutions Inc. reports total compensation of $5,321,147 for Joseph Papa in fiscal 2025, including a base salary of $1,037,385. Disclosed compensation is on record for 9 fiscal years. Joseph Papa has spoken on 6 earnings calls across 3 companies, most recently for Emergent BioSolutions Inc. on October 29, 2025. Those appearances were for Emergent BioSolutions Inc. (EBS), Bausch & Lomb Corp (BLCO) and Bausch Health Companies Inc. (BHC). Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Bausch & Lomb Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Robert G. Kramer, Sr. (CEO and Board Member) and 7 others.
“I will start by providing third quarter highlights, and then Rich will review the third quarter financials. I'll return to review key business catalysts to drive growth.”
“I am pleased to report that we are making great progress and continue to execute our plan and are on track with our multiyear transformation. First, I want to thank all of our Emergent colleagues for their great work, staying focused on our mission to protect and save lives while advancing our turnaround priorities.”
“Hello, everyone, and thank you for joining us to discuss our fourth quarter and full year 2024 earnings. I'm joined today by Richard Lindahl, our Chief Financial Officer.”
“I'm joined today by Rich Lindahl, our Chief Financial Officer. Following my opening comments, Rich will detail our Q1 performance, provide updated guidance for the second quarter as well as our full-year outlook for 2024.”
“I will begin some comments about our Bausch + Lomb third quarter highlights. Sam Eldessouky, our CFO, will then review the third quarter financial results in detail and discuss our 2022 guidance.”
2024-01-01–present
Last confirmed March 20, 2026
Start not stated–present
Last confirmed March 20, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2024-01-01–present
BLCO
Medical Instruments & Supplies · Healthcare
CEO
Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Emergent BioSolutions Inc. (EBS) | President, Chief Executive Officer and Director | $1,037,385 | $5,321,147 |
| 2024 | Emergent BioSolutions Inc. (EBS) | President, Chief Executive Officer and Director | $800,000 | $5,862,562 |
| 2023 | Bausch & Lomb Corp (BLCO) | Former Chief Executive Officer | $283,077 | $9,528,086 |
| 2022 | Bausch & Lomb Corp (BLCO) | Former Chief Executive Officer | $1,600,000 | $19,781,761 |
| 2021 | Bausch & Lomb Corp (BLCO) | Former Chief Executive Officer | $1,600,000 | $22,889,137 |
| 2021 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,600,000 | $22,889,137 |
| 2020 | Bausch & Lomb Corp (BLCO) | Chief Executive Officer | $1,526,539 | $14,119,361 |
| 2020 | Bausch Health Companies Inc. (BHC) | Former Chief Executive Officer | $1,526,539 | $14,119,361 |
| 2019 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $17,141,646 |
| 2018 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $14,741,050 |
| 2017 | Bausch Health Companies Inc. (BHC) | Chief Executive Officer | $1,500,000 | $4,895,108 |
